Daiwa Securities Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Daiwa Securities Group’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-145	Closed	–	–	1409
2023 Q3	$0	Hold	145	–	–	﹤0.01%	1347
2023 Q2	$0	Hold	145	–	–	﹤0.01%	1360
2023 Q1	$0	Hold	145	–	–	﹤0.01%	1329
2022 Q4	$1K	Hold	145	–	–	﹤0.01%	1301
2022 Q3	$2K	Hold	145	–	–	﹤0.01%	1255
2022 Q2	$1K	Hold	145	–	–	﹤0.01%	1333
2022 Q1	$1K	Hold	145	–	–	﹤0.01%	1354
2021 Q4	$1K	Hold	145	–	–	﹤0.01%	1368
2021 Q3	$2K	Buy	145 +73	+101%	+$1.19K	﹤0.01%	1253
2021 Q2	$2K	Hold	72	–	–	﹤0.01%	1164
2021 Q1	$2K	Hold	72	–	–	﹤0.01%	1169
2020 Q4	$1K	Sell	72 -140	-66%	-$2.09K	﹤0.01%	1221
2020 Q3	$2K	Hold	212	–	–	﹤0.01%	1150
2020 Q2	$2K	Hold	212	–	–	﹤0.01%	1169
2020 Q1	$2K	Hold	212	–	–	﹤0.01%	1171
2019 Q4	$6K	Sell	212 -26	-11%	-$608	﹤0.01%	1098
2019 Q3	$5K	Hold	238	–	–	﹤0.01%	1080
2019 Q2	$7K	Hold	238	–	–	﹤0.01%	1075
2019 Q1	$4K	Buy	238 +81	+52%	+$1.54K	﹤0.01%	1100
2018 Q4	$3K	Hold	157	–	–	﹤0.01%	1098
2018 Q3	$8K	Hold	157	–	–	﹤0.01%	1060
2018 Q2	$7K	Hold	157	–	–	﹤0.01%	1077
2018 Q1	$6K	Buy	+157	New	+$4.19K	﹤0.01%	1067

Other funds holding GTHX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Daiwa Securities Group's GTHX Position: Q4 2023 in Review

Daiwa Securities Group sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2023, closing a stake of 145 shares.

Daiwa Securities Group first reported a position in GTHX in Q1 2018 and held it in 23 quarters. The position peaked at $8K in Q3 2018. 87 funds tracked by Wall St. Rank hold GTHX as of Q4 2023.

Daiwa Securities Group reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Daiwa Securities Group sold 145 G1 Therapeutics, Inc. Common Stock shares in Q4 2023.
Daiwa Securities Group first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 23 quarters.
Daiwa Securities Group's G1 Therapeutics, Inc. Common Stock position peaked at $8K in Q3 2018.
87 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.